The week in health tech, explained in plain English.Get the free newsletter →
October 25, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

Four States Push New Hospital Violence Laws in 2026

Workplace violence against healthcare workers remains one of the industry's most stubborn safety problems, and state lawmakers are responding. According to Becker's Hospital Review, at least four states have passed or introduced new or expanded legislation in 2026 aimed at protecting hospital staff, with measures spanning formal prevention-planning requirements and prohibitions on weapons inside facilities.

The legislative activity follows a grim stretch. Becker's reported at least six hospital shootings in the first six months of the year, underscoring why prevention planning, reporting mandates, and physical security rules are moving up the policy agenda.

In practice, hospitals in affected states will need to formalize violence prevention programs, document incidents, and tighten access and weapons policies rather than rely on ad hoc responses. For operators, that means budgeting for security infrastructure, staff training, and compliance tracking. Because the rules vary by state, multi-state health systems face a patchwork of obligations that will require coordinated legal and operational review heading into 2026.

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.